Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-03-24 22:26 CET (UTC+1h)

half-life in multiple-dosed steady-state BE/BA study? [NCA / SHAM]

posted by yjlee168 Homepage - Kaohsiung, Taiwan, 2009-07-14 14:16  - Posting: # 3954
Views: 8,280

Dear All,

I just like to know if it is reasonable to estimate lambdaz when doing data analysis of a multiple-dosed steady-state (SS) BE/BA study. It is because we just collect the plasma/blood sample within one dosing interval (Tau) at steady-state in a multiple-dosed BE/BA study. It looks like there is no such terminal phase at all in multiple-dosed BE/BA study. If it is not reasonable, is there any way to estimate the elimination rate constant (kel), half-life, Vss or the accumulation index? In WinNonlin v5.x, lambdaz still needs to be estimated first for further calculations of other NCA parameters. Thanks in advanced.

All the best,
---Yung-jin Lee
[image]bear v2.8.3:- created by Hsin-ya Lee & Yung-jin Lee
Kaohsiung, Taiwan
Download link (updated) -> here

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
18,076 Posts in 3,845 Threads, 1,139 registered users;
30 users online (0 registered, 30 guests).

It is better to be wrong than to be vague.
In trial and error, the error is the true essential.    Freeman Dyson

BEBAC Ing. Helmut Schütz